Effects of calcipotriol on stratum corneum barrier function, hydration and cell renewal in humans

British Journal of Dermatology

Volumn 135, Issue 4, 1996, Pages 545-549

  Effendy, I ^a,b   Kwangsukstith, C ^b   Chiappe, M ^b   Maibach, H I ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; DODECYL SULFATE SODIUM;

ADULT; ARTICLE; CELL RENEWAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

EID: 0029842555     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb03828.x     Document Type: Article

References (32)

1. Kragballe K. Trement of psoriasis with calcipotriol and other vitamin D analogues. J Am Acad Dermatol 1992; 27: 1001-8.
2. Murdoch D, Clissold SP, Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992; 43: 415-29.
3. Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37: 889-95.
4. Vilaplana J, Mascaró JM, Lecha M, Romaguera C. Low irritancy of 2-day occlusive patch test with calcipotriol cream. Contact Dermatitis 1994; 30: 45-6.
5. Serup J, Fullerton A. Safety and skin irritation with vitamin D. In: Book of Abstracts of the 6th International Psoriasis Symposium. Chicago. 1994 (Abstr.).
6. 3 impair barrier function in normal mouse skin and in normal human skin. Arch Dermatol Res 1994; 286: 157 (Abstr.).
7. 3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990; 282: 164-7.
8. 3 analogue MC 903: modulations and interrelations. Br J Dermatol 1991; 124: 221-9.
9. Lee CH, Maibuch HI. The sodium lauryl sulfate model: an overview. Contact Dermatitis 1995; 33: 1-7.
10. Jansen LH, Hojyo-Tomoko MT, Kligman AM. Improved fluorescence staining technique for estimating turnover of the human stratum cornum. Br J Dermatol 1974; 90: 9-12.
11. Frosch PJ, Kligman AM. The soap chamber test: a new method for assessing the irritancy of soaps. J Am Acad Dermatol 1979; 1: 35-41.
12. Widmer J, Elsner P, Burg G. Skin irritant reactivity following experimental cumulative irritant contact dermatitis. Contact Dermatitis 1994; 30: 35-9.
13. Wilhelm KP, Freltag G, Wolff HH. Surfactant-induced skin irritation and skin repair evaluation of a cumulative human irritation model by noninvasive techniques. J Am Acad Dermatol 1994; 31: 981-7.
14. van der Valk PJM, Nater JP, Bleumink E. Skin irritancy of surfactants as assessed by water vapor loss measurements. J Invest Dermatol 1984; 82: 291-3.
15. Berardesca E, Maibuch HI. Bioengineering and the patch test. Contact Dermatitis 1988; 18: 3-9.
16. Wilhelm KP, Surber C, Maibach HI. Quantification of sodium lauryl sulfate irritant dermatitis in man: comparison of four techniques: skin color reflectance, trasepidermal water loss. laser Doppler flow measurement and visual scores. Arch Dermatol Res 1989; 281: 293-5.
17. Agner T, Serup J, Sodium lauryl sulphate for irritant patch testing - A dose-response study using bioengineering methods for determination of skin irritation. J Invest Dermatol 1990; 95: 543-7.
18. Rietschel RL. Irritant dermatitis: Diagnosis and treatment. In: Exoagenous Dermatoses (Menné T, Maibach HI, eds). Boca Raton: CRC, 1991; 375-9.
19. Agner T, Serup J. Skin reactions to irritants assessed by noninvasive, bioengineering methods. Contact Dermatitis 1989; 20: 352-9.
20. Tupker RA. Prediction of irritancy. In: Bioengineering of the Skin: Water and the Stratum Corneum (Elsner P, Berardesca E, Maibach HI, eds). Boca Raton: CRC, 1994: 69-81.
21. Dahl MV, Trandk RJ. Sodium lauryl sulfate irritant patch test: degree of inflammation at various times. Contact Dermatitis 1977; 3: 263-6.
22. Levy J, Gassmüller J, Schröder G et al. Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol 1994; 7: 231-6.
23. Marks R, Black D, Hamami I et al. A simplified method for measurement of desquamation using dansyl chloride fluorescence. Br J Dermatol 1984; 111: 265-70.
24. Ridge BD, Batt MD, Palmer HE, Jarrett A. The dansyl chloride technique for stratum comeum renewal as an indicator of changes in eṗidermal mitotic activity following topical treatment. Br J Dermatol 1988; 118: 167-74.
25. Roberts D, Marks R. The determination of regional and age variations in the rate of desquamation: A comparison of four techniques. J Invest Dermatol 1980; 74: 13-16.
26. Wilhelm KP, Saunders JC, Maibach HI. Increased stratum corneum turnover induced by subclinical irritant dermatitis. Br J Dermatol 1990; 122: 793-8.
27. Piérard GE. Microscopic evaluation of the dansyl chloride test. Dermatology 1992; 185: 37-40.
28. Paye M, Simion FA, Piérard GE. Dansyl chloride labelling of stratum corneum: Its rapid extraction from skin can predict skin irritatlon due to surfactants and cleansing products. Contact Dermatitis 1994; 30: 91-6.
29. Effendy I, Kwangsukstith C, Lee YL, Maibach HI. Functional changes in human stratum comeum induced by topical glycolic acid: Comparison with all-trans retinoic acid. Acta Derm Venereol (Stockh) 1995; 75: 455-8.
30. 3 and the vitamin D analogue KH 1060 induce hyperproliferation in normal mouse epidermis. J Invest Dermatol 1992; 98: 525 (Abstr.).
31. 3 treatment in psoriasis vulgaris. Br J Dermatol 1986; 115: 421-9.
32. 3 can be a safe and effective therapy for psoriasis. J Am Acad Dermatol 1988; 19: 516-28.